These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 25022590)
1. Characterization of a melamino nitroheterocycle as a potential lead for the treatment of human african trypanosomiasis. Giordani F; Buschini A; Baliani A; Kaiser M; Brun R; Barrett MP; Pellacani C; Poli P; Gilbert IH Antimicrob Agents Chemother; 2014 Oct; 58(10):5747-57. PubMed ID: 25022590 [TBL] [Abstract][Full Text] [Related]
2. Identification and Characterization of FTY720 for the Treatment of Human African Trypanosomiasis. Jones AJ; Kaiser M; Avery VM Antimicrob Agents Chemother; 2015 Dec; 60(3):1859-61. PubMed ID: 26666915 [TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics, Trypanosoma brucei gambiense efficacy, and time of drug action of DB829, a preclinical candidate for treatment of second-stage human African trypanosomiasis. Wenzler T; Yang S; Braissant O; Boykin DW; Brun R; Wang MZ Antimicrob Agents Chemother; 2013 Nov; 57(11):5330-43. PubMed ID: 23959303 [TBL] [Abstract][Full Text] [Related]
4. Antitrypanosomal activity of fexinidazole, a new oral nitroimidazole drug candidate for treatment of sleeping sickness. Kaiser M; Bray MA; Cal M; Bourdin Trunz B; Torreele E; Brun R Antimicrob Agents Chemother; 2011 Dec; 55(12):5602-8. PubMed ID: 21911566 [TBL] [Abstract][Full Text] [Related]
5. The phenomenon of treatment failures in Human African Trypanosomiasis. Brun R; Schumacher R; Schmid C; Kunz C; Burri C Trop Med Int Health; 2001 Nov; 6(11):906-14. PubMed ID: 11703845 [TBL] [Abstract][Full Text] [Related]
6. Impact of mass chemotherapy in domestic livestock for control of zoonotic T. b. rhodesiense human African trypanosomiasis in Eastern Uganda. Fyfe J; Picozzi K; Waiswa C; Bardosh KL; Welburn SC Acta Trop; 2017 Jan; 165():216-229. PubMed ID: 27570206 [TBL] [Abstract][Full Text] [Related]
7. New treatment option for second-stage African sleeping sickness: in vitro and in vivo efficacy of aza analogs of DB289. Wenzler T; Boykin DW; Ismail MA; Hall JE; Tidwell RR; Brun R Antimicrob Agents Chemother; 2009 Oct; 53(10):4185-92. PubMed ID: 19620327 [TBL] [Abstract][Full Text] [Related]
8. A new nonpolar N-hydroxy imidazoline lead compound with improved activity in a murine model of late-stage Trypanosoma brucei brucei infection is not cross-resistant with diamidines. Ríos Martínez CH; Miller F; Ganeshamoorthy K; Glacial F; Kaiser M; de Koning HP; Eze AA; Lagartera L; Herraiz T; Dardonville C Antimicrob Agents Chemother; 2015 Feb; 59(2):890-904. PubMed ID: 25421467 [TBL] [Abstract][Full Text] [Related]
9. Novel S-adenosylmethionine decarboxylase inhibitors for the treatment of human African trypanosomiasis. Barker RH; Liu H; Hirth B; Celatka CA; Fitzpatrick R; Xiang Y; Willert EK; Phillips MA; Kaiser M; Bacchi CJ; Rodriguez A; Yarlett N; Klinger JD; Sybertz E Antimicrob Agents Chemother; 2009 May; 53(5):2052-8. PubMed ID: 19289530 [TBL] [Abstract][Full Text] [Related]
10. The story of CGP 40 215: studies on its efficacy and pharmacokinetics in African green monkey infected with Trypanosoma brucei rhodesiense. Brun R; Burri C; Gichuki CW Trop Med Int Health; 2001 May; 6(5):362-8. PubMed ID: 11348531 [TBL] [Abstract][Full Text] [Related]
11. 100 Years of Suramin. Wiedemar N; Hauser DA; Mäser P Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31844000 [TBL] [Abstract][Full Text] [Related]
13. Antitrypanosomal Chloronitrobenzamides. Carrillo AK; Kadayat TM; Hwang JY; Chen Y; Zhu F; Holbrook G; Gillingwater K; Connelly MC; Yang L; Kaiser M; Guy RK J Med Chem; 2024 Mar; 67(5):3437-3447. PubMed ID: 38363074 [TBL] [Abstract][Full Text] [Related]
14. Cynaropicrin: the first plant natural product with in vivo activity against Trypanosoma brucei. Zimmermann S; Kaiser M; Brun R; Hamburger M; Adams M Planta Med; 2012 Apr; 78(6):553-6. PubMed ID: 22331812 [TBL] [Abstract][Full Text] [Related]
15. [In vivo resistance to strains of Trypanosoma rhodesiense, Mozambique, 1985]. Pérez Martín O; Lastre González M; Urban M; Shwalbach J Rev Cubana Med Trop; 1991; 43(3):189-93. PubMed ID: 9768188 [TBL] [Abstract][Full Text] [Related]
16. Arsenicals (melarsoprol), pentamidine and suramin in the treatment of human African trypanosomiasis. Nok AJ Parasitol Res; 2003 May; 90(1):71-9. PubMed ID: 12743807 [TBL] [Abstract][Full Text] [Related]
17. Efficacy of the novel diamidine compound 2,5-Bis(4-amidinophenyl)- furan-bis-O-Methlylamidoxime (Pafuramidine, DB289) against Trypanosoma brucei rhodesiense infection in vervet monkeys after oral administration. Mdachi RE; Thuita JK; Kagira JM; Ngotho JM; Murilla GA; Ndung'u JM; Tidwell RR; Hall JE; Brun R Antimicrob Agents Chemother; 2009 Mar; 53(3):953-7. PubMed ID: 19064893 [TBL] [Abstract][Full Text] [Related]
18. Evaluating the impact of targeting livestock for the prevention of human and animal trypanosomiasis, at village level, in districts newly affected with T. b. rhodesiense in Uganda. Hamill L; Picozzi K; Fyfe J; von Wissmann B; Wastling S; Wardrop N; Selby R; Acup CA; Bardosh KL; Muhanguzi D; Kabasa JD; Waiswa C; Welburn SC Infect Dis Poverty; 2017 Feb; 6(1):16. PubMed ID: 28162093 [TBL] [Abstract][Full Text] [Related]
19. Occurrence of multiple drug resistance in Trypanosoma brucei rhodesiense isolated from sleeping sickness patients. Kagira JM; Maina N Onderstepoort J Vet Res; 2007 Mar; 74(1):17-22. PubMed ID: 17708149 [TBL] [Abstract][Full Text] [Related]
20. Differential virulence of Trypanosoma brucei rhodesiense isolates does not influence the outcome of treatment with anti-trypanosomal drugs in the mouse model. Ndung'u K; Murilla GA; Thuita JK; Ngae GN; Auma JE; Gitonga PK; Thungu DK; Kurgat RK; Chemuliti JK; Mdachi RE PLoS One; 2020; 15(11):e0229060. PubMed ID: 33151938 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]